Podcast: US tariff information and Q2 earnings affect pharma developments
After months of negotiations, the EU and US reached an settlement to levy a 15% tariff on EU imports, which incorporates together with tariffs on particular sectors, just like the drug imports.
On this episode, the healthcare reporting workforce dives into the newest spherical of tariffs and different regulatory insurance policies which might be set to immediately have an effect on the pharma sector.
GlobalData Insights Manasi Vaidya sat down to debate the information with Robert Barrie, a reporter for Pharmaceutical Expertise, who has written about a number of of those developments in the previous few weeks.
The second half of the episode additionally incorporates snippets of an interview with Dr. Mariana Socal, a well being economist from the Johns Hopkins Bloomberg Public College of Well being, concerning the quick and long run penalties of those insurance policies on the event and pricing for these medication.
Navigate the shifting tariff panorama with real-time information and market-leading evaluation.
Request a free demo for GlobalData’s Strategic Intelligence right here.
Join our day by day information round-up!
Give your corporation an edge with our main trade insights.
